Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.
Mitera Biosciences has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Mitera Biosciences's investors include Cedars Sinai.
Mitera Biosciences is headquartered in Bellevue, United States.
Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.
Mitera Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mitera Biosciences — Funding & Investors." VCBacked, December 30, 2025, https://www.vcbacked.co/company/mitera-biosciences. Accessed November 13, 2026.
VCBacked. (2025). Mitera Biosciences — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/mitera-biosciences
{{cite web |title=Mitera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/mitera-biosciences |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Mitera Biosciences? Request a listing update